Life ScienceCompany
Healion Bio - Preclinical Infectious Disease Portfolio Ownership
Who owns Healion Bio - Preclinical Infectious Disease Portfolio?
Healion Bio - Preclinical Infectious Disease Portfolio is owned by Tonix Pharmaceuticals Holding. It was acquired on February 2, 2023.
Healion Bio - Preclinical Infectious Disease Portfolio Business Overview
Where is Healion Bio - Preclinical Infectious Disease Portfolio headquartered?
Healion Bio - Preclinical Infectious Disease Portfolio is headquartered in Frederick, Maryland.
What sector is Healion Bio - Preclinical Infectious Disease Portfolio in?
Healion Bio - Preclinical Infectious Disease Portfolio is a life science company.
Life Science M&A Summary in 2023
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.
Join Mergr to view all 198 acquisitions of life science companies in 2023, including 24 acquisitions by private equity firms, and 174 by strategics.